Skip to Main Content

Paper Details

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.
BMC Nephrol
1
2023
Author NameAffiliation
Stuart L GoldsteinCenter for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine
Franz SchaeferUniversity Children's Hospital Heidelberg
  • 1 - 2

Datasets

Release 1.2